| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |